Kensey Nash Corporation (Nasdaq: KNSY) submitted a response to the FDA comments focused on labeling and clarification of previously ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE